Donor Genotype in the Interleukin-7 Receptor α-Chain Predicts Risk of Graft-versus-Host Disease and Cytomegalovirus Infection after Allogeneic Hematopoietic Stem Cell Transplantation
The efficacy of allogeneic hematopoietic stem cell transplantation (HSCT) is challenged by acute and chronic graft-versus-host disease (aGVHD and cGVHD) and viral infections due to long-lasting immunodeficiency. Interleukin-7 (IL-7) is a cytokine essential for de novo T cell generation in thymus and...
Main Authors: | Katrine Kielsen, Christian Enevold, Carsten Heilmann, Henrik Sengeløv, Anders Elm Pedersen, Lars P. Ryder, Klaus Müller |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-02-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fimmu.2018.00109/full |
Similar Items
-
Cytomegalovirus management after allogeneic hematopoietic stem cell transplantation: A mini-review
by: Chieh-Lin Jerry Teng, et al.
Published: (2021-06-01) -
Cost-effectiveness analysis of the use of letermovir for the prophylaxis of cytomegalovirus in adult cytomegalovirus seropositive recipients undergoing allogenic hematopoietic stem cell transplantation in Italy
by: Restelli U, et al.
Published: (2019-05-01) -
Mutations in the cytomegalovirus UL97 gene associated with ganciclovir resistance in recipients of allogeneic hematopoietic stem cell transplants
by: Demin M.V., et al.
Published: (2019-12-01) -
The risk factors for cytomegalovirus reactivation following stem cell transplantation
by: Bahareh Valadkhani, et al.
Published: (2016-01-01) -
Valganciclovir for cytomegalovirus preemptive therapy in patients following allogeneic hematopoietic stem cell transplantation
by: LU Xuan, et al.
Published: (2020-09-01)